In a large observational study of patients receiving home kidney dialysis, home hemodialysis was associated with improvements in key cardiovascular outcomes compared with peritoneal dialysis; however, ...
Raludotatug deruxtecan (R-DXd) received FDA breakthrough therapy designation for CDH6-expressing platinum-resistant ovarian, primary peritoneal, or fallopian tube cancers. Phase 1 study demonstrated a ...
Researchers have found in a new study that Calcium and PPI use, history of upper gastrointestinal bleeding (UGIB), hemoglobin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback